MarketCapExport financials
GlycoMimetics (GLYC)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
GlycoMimetics Income Statement 2025-2011 | GLYC
Brief overview of revenue and earnings at GlycoMimetics
The conclusions below are based on five years of reported results. According to figures from GlycoMimetics, revenue changed from $10.2 million to $10.8 million over five years. The cumulative result was +6.7%, corresponding to roughly 1.3% per year. Sales changed only slightly and remained broadly flat.
The five-year EBITDA result moved by −197.7%: from −$51.2 million to −$153 million. Changes in revenue did not translate into comparable EBITDA performance. Comparing the endpoints gives EBITDA margins of −504.2% and −1406.8%. Operating return per unit of revenue declined.
Net income moved from −$51 million at the start to −$154 million at the end. Larger losses indicate rising pressure on the business.
What the figures show
The indicators point to a weaker financial profile. The most visible risks are a declining EBITDA margin, lower net income and limited revenue growth. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement GlycoMimetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 18.1 M | 201 M | 72.5 M | 74.1 M | 172 M | 186 M | 460 M | 663 M | 118 M | 89.5 M | 136 M | 11.5 M | - | - |
Shares |
27.6 M | 64.5 M | 63.3 M | 52.5 M | 51.5 M | 45.7 M | 43.3 M | 41 M | 29.4 M | 21.3 M | 19 M | 18.5 M | 1.2 M | - | - |
Historical Prices |
- | 0.28 | 3.18 | 1.38 | 1.44 | 3.76 | 5.29 | 9.47 | 16.8 | 6.1 | 5.72 | 7.2 | - | - | - |
Net Income |
154 K | 37.9 K | 36.9 K | -46.7 M | -63.4 M | -51 M | -57.9 M | -48.3 M | -33.3 M | -31.8 M | -12.8 M | -11.1 M | -10.6 M | 3.66 M | -6.11 M |
Revenue |
10.8 M | - | 10 K | 75 K | 1.16 M | 10.2 M | - | - | - | 18.5 K | 20.1 M | 15 M | 3.99 M | 15.3 M | 3.81 M |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | 20.1 M | 15 M | 3.99 M | 15.3 M | - |
Operating Income |
-153 M | -17.2 M | -39.3 M | -47.4 M | -63.4 M | -51.5 M | -61.4 M | -51.5 M | -33.9 M | -31.9 M | -12.8 M | -11.1 M | -10.6 M | 3.64 M | - |
Interest Expense |
- | - | - | - | - | - | - | - | 651 K | 104 K | 15.3 K | 18.2 K | 894 | 21 K | - |
EBITDA |
-153 M | -17.2 M | -39.1 M | -47.2 M | -63.2 M | -51.2 M | -61.1 M | -51.2 M | -33.7 M | -31.7 M | -12.6 M | -11 M | -10.5 M | 3.76 M | -6 M |
Operating Expenses |
163 M | 17.2 M | 39.3 M | 47.5 M | 64.6 M | 61.7 M | 61.4 M | 51.5 M | 33.9 M | 31.9 M | 32.9 M | 26.2 M | 14.6 M | 11.6 M | - |
General and Administrative Expenses |
25.4 M | 3.16 M | 19.2 M | 19.1 M | 17.1 M | 16.7 M | 14.4 M | 11.4 M | 9.83 M | 8.65 M | 7.8 M | 6.6 M | - | 2.16 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement GlycoMimetics
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
27.8 M | 27.6 M | 27.6 M | 13.9 M | 13.9 M | 64.5 M | 1.02 M | 64.5 M | 64.5 M | 64.5 M | 64.4 M | 64.3 M | 64.3 M | 60.4 M | 54.4 M | 52.4 M | 52.4 M | 52.3 M | 52.3 M | 51.6 M | 51.5 M | 50.7 M | 49 M | 47.5 M | 43.8 M | 43.6 M | 43.5 M | 43.3 M | 43.2 M | 43.2 M | 43.2 M | 43.1 M | 42.8 M | 35.2 M | 34.4 M | 32.7 M | 27.2 M | 23.5 M | 23.3 M | 23 M | 19.8 M | 19.1 M | 19.1 M | 19 M | 19 M | 19 M | 18.9 M | 18.9 M | 18.8 M | 17.2 M | 1.43 M | 1.23 M | 946 K | 931 K | - | - | - | - | - | - | - | - |
Net Income |
-24.8 M | -23.3 M | -23.3 M | -24.6 M | -21.8 M | -2.34 M | - | -9.82 M | -10.1 M | -10.7 M | - | -9.2 M | -8.26 M | -10.4 M | - | -8.52 M | -13.3 M | -14.7 M | - | -17.3 M | -14.4 M | -14.3 M | - | -13.7 M | -14.1 M | -7.66 M | -14.7 M | -13.3 M | -15.8 M | -14.1 M | -13.9 M | -11.6 M | -11.3 M | -11.5 M | -9.26 M | -7.95 M | -8.14 M | -7.93 M | -8.33 M | -7.85 M | -8.07 M | -7.55 M | -8.88 M | -7.17 M | 10.4 M | -7.11 M | -7.39 M | -6.62 M | 7.99 M | -5.1 M | -3.87 M | -3.7 M | -3.5 M | 460 K | - | - | - | - | - | - | - | - |
Revenue |
- | 1.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 75 K | 75 K | - | - | 86.6 K | 142 | 1.06 M | - | 1 M | 9 M | 9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 18.5 K | - | - | 35.4 K | 20 M | 20 M | - | - | 15 M | 15 M | - | 77.4 K | 52.6 K | 55.1 K | 3.81 M | - | - | - | - | - | - | - | - |
Operating Income |
-26.4 M | -24.7 M | - | -25.9 M | -21 M | -2.4 M | - | -11.2 M | -10.4 M | -11.1 M | - | -9.81 M | -8.93 M | -10.9 M | - | -8.77 M | -13.4 M | -14.7 M | - | -17.3 M | -14.4 M | -14.3 M | - | -13.7 M | -14.1 M | -8.11 M | - | -14.1 M | -16.8 M | -15.1 M | - | -12.5 M | -12.1 M | -12.1 M | - | -8.18 M | -8.24 M | -7.97 M | - | -7.89 M | -8.09 M | -7.58 M | - | -7.17 M | 10.4 M | -7.11 M | - | -6.7 M | 8.06 M | -5.11 M | - | -3.7 M | -3.5 M | 459 K | - | - | - | - | - | - | - | - |
Interest Expense |
1.53 M | 1.45 M | - | 1.28 M | -760 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 944 K | 870 K | 364 K | - | 232 K | 102 K | 39.5 K | - | 32.1 K | 21.8 K | 20.1 K | - | 3.3 K | 2.64 K | 3.56 K | - | 4.83 K | 4.26 K | 4.77 K | - | 16 | -104 | - | - | - | - | - | - | - | - | - |
EBITDA |
-26.2 M | -24.7 M | - | - | - | - | - | - | - | -11.1 M | - | -9.77 M | -8.89 M | -10.9 M | - | -8.72 M | -13.3 M | -14.6 M | - | -17.3 M | -14.3 M | -14.2 M | - | -13.7 M | -14 M | -8.04 M | - | -14 M | -16.7 M | -15.1 M | - | -12.5 M | -12.1 M | -12.1 M | - | -8.11 M | -8.17 M | -7.92 M | - | -7.84 M | -8.05 M | -7.53 M | - | -7.12 M | 10.4 M | -7.07 M | - | -6.66 M | 8.1 M | -5.07 M | - | -3.67 M | -3.46 M | 491 K | - | - | - | - | - | - | - | - |
Operating Expenses |
28.1 M | 25.8 M | - | 25.9 M | 21 M | 2.4 M | - | 11.2 M | 10.4 M | 11.1 M | - | 9.81 M | 8.93 M | 10.9 M | - | 8.77 M | 13.4 M | 14.7 M | - | 17.4 M | 14.4 M | 15.3 M | - | 14.7 M | 14.1 M | 17.1 M | - | 14.1 M | 16.8 M | 15.1 M | - | 12.5 M | 12.1 M | 12.1 M | - | 8.18 M | 8.24 M | 7.97 M | - | 7.91 M | 8.09 M | 7.58 M | - | 7.17 M | 9.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.74 M | 7.86 M | - | 5.54 M | 8.95 M | 2.38 M | - | 4.01 M | 4.07 M | 5.09 M | - | 4.52 M | 4.86 M | 5.52 M | - | 3.84 M | 5.45 M | 5.06 M | - | 4.14 M | 4.24 M | 4.19 M | - | 4.06 M | 4.23 M | 4.44 M | - | 3.38 M | 3.75 M | 3.36 M | - | 2.79 M | 2.85 M | 2.85 M | - | 2.4 M | 2.52 M | 2.09 M | - | 1.98 M | 2.31 M | 2.06 M | - | 2.13 M | 1.81 M | 1.9 M | - | 1.65 M | 1.61 M | 1.22 M | - | 800 K | 668 K | 606 K | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company GlycoMimetics (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Canada
USA
Russia
Niderland
Israel
Spain
Germany
Australia
Britain
